{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:07:27Z","timestamp":1784700447299,"version":"3.55.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:p>Chronic kidney disease (CKD) represents a growing global health challenge associated with substantial morbidity, mortality, and healthcare burden. Although metabolic and haemodynamic factors, particularly diabetes mellitus and hypertension, remain major contributors, increasing evidence demonstrates that persistent inflammation and immune dysregulation are central mechanisms influencing CKD initiation, progression, and complications. The renal immune microenvironment consists of complex interactions among resident kidney cells, infiltrating immune cells, inflammatory mediators, and molecular signalling networks that regulate tissue repair, fibrosis, and disease outcomes. Persistent activation of innate and adaptive immune responses promotes cytokine release, oxidative stress, endothelial dysfunction, and maladaptive tissue remodelling, contributing to progressive loss of kidney function. Infectious diseases and altered host\u2013microbiome interactions may further amplify systemic inflammation and immune imbalance, particularly in vulnerable populations. Advances in immunology and molecular medicine have identified inflammatory biomarkers and immune-related pathways with potential applications in early detection, risk stratification, and targeted interventions. This Mini Review synthesizes current evidence linking inflammation, infection, and immune dysregulation with CKD progression, highlighting translational opportunities and epidemiological perspectives. Integrating mechanistic insights with population-level evidence may accelerate precision approaches for improving CKD prevention, monitoring, and therapeutic outcomes.<\/jats:p>","DOI":"10.3389\/fneph.2026.1919658","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:56:27Z","timestamp":1784699787000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammation, infection, and immune dysregulation in chronic kidney disease: translational and epidemiological perspectives"],"prefix":"10.3389","volume":"6","author":[{"given":"Aminu","family":"Shittu","sequence":"first","affiliation":[{"name":"Department of Veterinary Public Health and Preventive Medicine, Faculty of Veterinary Medicine, Usmanu Danfodiyo University","place":["Sokoto, Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1526482","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"16","author":"Xie","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073330","article-title":"Comprehending the role of metabolic and hemodynamic factors alongside different signaling pathways in the pathogenesis of diabetic nephropathy","volume":"26","author":"Ratan","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14101259","article-title":"Stress pathways in chronic kidney disease: linking cortisol, oxidative stress, and inflammation","volume":"14","author":"Motrenikova","year":"2025","journal-title":"Antioxidants"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nri3523","article-title":"The immune system and kidney disease: basic concepts and clinical implications","volume":"13","author":"Kurts","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2017.12.016","article-title":"Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets","volume":"820","author":"Lv","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0110-2","article-title":"Macrophages: versatile players in renal inflammation and fibrosis","volume":"15","author":"Tang","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv466","article-title":"Chronic kidney disease in low- and middle-income countries","volume":"31","author":"Stanifer","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1038\/s41598-026-35676-2","article-title":"Factors associated with chronic kidney disease among patients with hepatitis c infection attending Kigeme district hospital, Rwanda","volume":"16","author":"Ndatumuremyi","year":"2026","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/biom16040559","article-title":"Spatiotemporal control of intercellular crosstalk: a new therapeutic paradigm for halting acute kidney injury to chronic kidney disease transition","volume":"16","author":"Su","year":"2026","journal-title":"Biomolecules"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1750484","article-title":"Unveiling the immune microenvironment in diabetic nephropathy: from mechanisms to therapeutics","volume":"17","author":"Jiang","year":"2026","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c120028","article-title":"Immune and inflammatory role in renal disease","volume":"3","author":"Imig","year":"2013","journal-title":"Compr Physiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13119","article-title":"The role of the immune system in kidney disease","volume":"192","author":"Tecklenborg","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014010117","article-title":"Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis","volume":"25","author":"Anders","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s44466-026-00040-6","article-title":"Toll-like receptors in innate immunity and inflammation: from fundamental biology to clinic insights","volume":"2","author":"Qian","year":"2026","journal-title":"Immun Inflammation"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-020712-163930","article-title":"Host responses in tissue repair and fibrosis","volume":"8","author":"Duffield","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13725","article-title":"Role of the adaptive immune system in diabetic kidney disease","volume":"13","author":"Kong","year":"2022","journal-title":"J Diabetes Investig"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2180373","article-title":"Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome","volume":"2018","author":"Mihai","year":"2018","journal-title":"J Immunol Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1526090","article-title":"Advances in kidney disease: pathogenesis and therapeutic targets","volume":"12","author":"Boima","year":"2025","journal-title":"Front Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1335094","article-title":"The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis","volume":"14","author":"Ren","year":"2024","journal-title":"Front Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010088","article-title":"Oxidative stress and mitochondrial dysfunction in chronic kidney disease","volume":"12","author":"Ho","year":"2022","journal-title":"Cells"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13020142","article-title":"Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets","volume":"13","author":"Lim","year":"2021","journal-title":"Toxins (Basel)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-021-01153-4","article-title":"The innate immune system in human kidney inflammaging","volume":"35","author":"Sepe","year":"2022","journal-title":"J Nephrol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2018.12.002","article-title":"Common mechanisms of viral injury to the kidney","volume":"26","author":"Bruggeman","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04320416","article-title":"Viral-associated GN: hepatitis C and HIV","volume":"12","author":"Kupin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115183","article-title":"Sepsis-mediated renal dysfunction: pathophysiology, biomarkers and role of phytoconstituents in its management","volume":"165","author":"Balkrishna","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000528685","article-title":"New frontiers in sepsis-induced acute kidney injury and blood purification therapies: the role of polymethylmethacrylate membrane hemofilter","author":"Stasi","year":"2023","journal-title":"Blood Purif"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110706","article-title":"Gut microbiome in patients with chronic kidney disease stages 4 and 5: a systematic literature review","volume":"26","author":"Suliman","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-026-05061-z","article-title":"Microbiome alterations and their potential impact on infection risk in chronic kidney disease and end-stage kidney disease: a narrative review","author":"Stefanelli","year":"2026","journal-title":"Int Urol Nephrol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0150-7","article-title":"Antimicrobial resistance in nephrology","volume":"15","author":"Wang","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102368","article-title":"Chronic kidney disease-an underestimated risk factor for antimicrobial resistance in patients with urinary tract infections","volume":"10","author":"Vacaroiu","year":"2022","journal-title":"Biomedicines"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkz325","article-title":"Mechanisms of antimicrobial-induced nephrotoxicity in children","volume":"75","author":"Downes","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2023.08.031","article-title":"Overview of antibiotic-induced nephrotoxicity","volume":"8","author":"Campbell","year":"2023","journal-title":"Kidney Int Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.70413","article-title":"A comprehensive review of advanced biomarkers for chronic kidney disease in older adults: current insights and future directions","volume":"16","author":"Pradeep","year":"2024","journal-title":"Cureus"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15101225","article-title":"Emerging biomarkers and advanced diagnostics in chronic kidney disease: early detection through multi-omics and AI","volume":"15","author":"Alobaidi","year":"2025","journal-title":"Diagnost (Basel)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"121139","DOI":"10.1016\/j.cca.2026.121139","article-title":"Inflammatory biomarkers in chronic kidney disease","volume":"591","author":"Oriquat","year":"2026","journal-title":"Clin Chim Acta"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9020182","article-title":"Review on inflammation markers in chronic kidney disease","volume":"9","author":"Petreski","year":"2021","journal-title":"Biomedicines"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-011-9261-3","article-title":"Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome","volume":"17","author":"Colombo","year":"2012","journal-title":"Heart Fail Rev"},{"key":"B40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12882-015-0068-7","article-title":"Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease","volume":"16","author":"Lee","year":"2015","journal-title":"BMC Nephrol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.02.336","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"60","author":"Bhavsar","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1177\/0192623320985045","article-title":"A review of specific biomarkers of chronic renal injury and their potential application in nonclinical safety assessment studies","volume":"49","author":"Obert","year":"2021","journal-title":"Toxicol Pathol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1778759","article-title":"Complement and inflammasome crosstalk in chronic inflammation","volume":"17","author":"Jan\u017ei\u010d","year":"2026","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2403645","article-title":"Epidemiological analysis of chronic kidney disease from 1990 to 2019 and predictions to 2030 by Bayesian age-period-cohort analysis","volume":"46","author":"Dong","year":"2024","journal-title":"Ren Fail"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1542329","article-title":"Global burden of chronic kidney disease and risk factors, 1990-2021: an update from the global burden of disease study 2021","volume":"13","author":"Wang","year":"2025","journal-title":"Front Public Health"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.318729","article-title":"Hypertension in low- and middle-income countries","volume":"128","author":"Schutte","year":"2021","journal-title":"Circ Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1193984","article-title":"Non-traditional risk factors of progression of chronic kidney disease in adult population: a scoping review","volume":"10","author":"Cisneros-Garc\u00eda","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2471\/BLT.17.206441","article-title":"The global burden of kidney disease and the sustainable development goals","volume":"96","author":"Luyckx","year":"2018","journal-title":"Bull World Health Organ"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-023-01172-5","article-title":"Emerging preventive strategies in chronic kidney disease: recent evidence and gaps in knowledge","volume":"25","author":"Pradhan","year":"2023","journal-title":"Curr Atheroscler Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157606","article-title":"Beyond blood pressure: emerging pathways and precision approaches in hypertension-induced kidney damage","volume":"26","author":"Delrue","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2026.1747053","article-title":"Molecular pathways and emerging therapeutic targets in the pathogenesis of diabetic kidney disease","volume":"17","author":"Al-Masri","year":"2026","journal-title":"Front Physiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27052244","article-title":"Developmental programming of kidney disease across the life course: a narrative review focused on inflammation","volume":"27","author":"Hsu","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"20386","DOI":"10.1038\/s41598-024-71416-0","article-title":"SGLT2 inhibition mitigates transition from acute kidney injury to chronic kidney disease by suppressing ferroptosis","volume":"14","author":"Hirashima","year":"2024","journal-title":"Sci Rep"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1574693","article-title":"Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety","volume":"12","author":"Zhang","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000001194","article-title":"Beneficial effects of sodium-glucose cotransporter 2 inhibitors in cisplatin nephrotoxicity: a mechanistic review","volume":"7","author":"Mathavan","year":"2026","journal-title":"Kidney360"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1678640","article-title":"Immune mechanisms in chronic kidney disease-mineral and bone disorder: current insights and therapeutic implications","volume":"12","author":"Xu","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70382","article-title":"Immunoglobulin A nephropathy: molecular pathogenesis and targeted therapy","volume":"6","author":"Zhou","year":"2025","journal-title":"MedComm (2020)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10238-026-02107-5","article-title":"Artificial intelligence in immunotherapy: revolutionizing diagnostic and therapeutic applications in cancer and autoimmune diseases","volume":"26","author":"Alshorman","year":"2026","journal-title":"Clin Exp Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41392-026-02631-6","article-title":"Multi-omics and artificial intelligence for precision drug discovery and potential clinical applications","volume":"11","author":"Liu","year":"2026","journal-title":"Signal Transd Targ Ther"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2026.1919658\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:56:28Z","timestamp":1784699788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2026.1919658\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":59,"alternative-id":["10.3389\/fneph.2026.1919658"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2026.1919658","relation":{},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1919658"}}